Possible viral oncolysis by members of the Reoviridae and Paramyxoviridae families (an in vitro study).
/in International Publications, Newcastle Disease VirusSTAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells
/in Immunogenic Cell Death, International Publications, Malignant Melanoma, Newcastle Disease VirusOncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Newcastle Disease VirusOncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis
/in Cervical Cancer, International Publications, Newcastle Disease VirusRegression of solid breast tumours in mice by Newcastle disease virus is associated with production of apoptosis related-cytokines
/in Breast Cancer, International Publications, Newcastle Disease VirusRecent Advances in Cancer Stem Cell-Targeted Immunotherapy
/in Dendritic Cells, International Publications, Newcastle Disease VirusImmunotherapy for Triple-Negative Breast Cancer: Latest Research and Clinical Prospects
/in Breast Cancer, Dendritic Cells, International Publications, Newcastle Disease VirusOncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease VirusCombining Tumor Vaccination and Oncolytic Viral Approaches with Checkpoint Inhibitors: Rationale, Pre-Clinical Experience, and Current Clinical Trials in Malignant Melanoma
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Melanoma, Newcastle Disease Virus
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de